| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/2011 | WO2011047340A1 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine |
| 04/21/2011 | WO2011047290A1 Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with annexin a1 short peptide |
| 04/21/2011 | WO2011047287A1 Methods of treating inflammatory and fibrotic lung diseases with substance p analogs |
| 04/21/2011 | WO2011047269A2 Elongator proteins and use thereof as dna demethylases |
| 04/21/2011 | WO2011047267A1 Chimeric fibroblast growth factors with altered receptor specificity |
| 04/21/2011 | WO2011047241A1 Enhanced substrates for the protease activity of serotype a botulinum neurotoxin |
| 04/21/2011 | WO2011047215A1 Improved peptidomimetic macrocycles |
| 04/21/2011 | WO2011047204A1 Method of treating memory disorders and enhancing memory using igf-ii compounds |
| 04/21/2011 | WO2011047188A1 Thrombopoietic compounds |
| 04/21/2011 | WO2011047183A2 Use of a neuregulin to treat peripheral nerve injury |
| 04/21/2011 | WO2011047172A1 Method of treating inflammation |
| 04/21/2011 | WO2011047135A2 Compositions and methods for treating bladder cancer |
| 04/21/2011 | WO2011047107A1 Enteral administration of arginine-glutamine dipeptide to support retinal, intestinal, or nervous system development |
| 04/21/2011 | WO2011047095A1 Reducing the risk of pathological effects of traumatic brain injury |
| 04/21/2011 | WO2011047093A2 Stem cells for musculoskeletal tissue repair |
| 04/21/2011 | WO2011047091A1 Methods for treating traumatic brain injury |
| 04/21/2011 | WO2011047051A2 Polymeric systems for the delivery of anticancer agents |
| 04/21/2011 | WO2011047047A2 Composites containing polypeptides attached to polysaccharides and molecules |
| 04/21/2011 | WO2011047011A2 Treatment and diagnosis of inflammatory disorders |
| 04/21/2011 | WO2011046832A2 Granulysin in immunotherapy |
| 04/21/2011 | WO2011046811A1 Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor |
| 04/21/2011 | WO2011046634A1 Infectious clones of torque teno virus |
| 04/21/2011 | WO2011046622A2 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
| 04/21/2011 | WO2011046583A1 Pharmaceutical exploitation of oxidative stress in transformed cells |
| 04/21/2011 | WO2011046568A1 Compositions and methods of treatment of black hemophiliac patients |
| 04/21/2011 | WO2011046160A1 Method for screening of substance capable of preventing virus infection, and agent for preventing virus infection |
| 04/21/2011 | WO2011046101A1 Fat accumulation suppressor |
| 04/21/2011 | WO2011045764A1 A product for delivering antimicrobially active substances to an infected site |
| 04/21/2011 | WO2011045668A1 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 04/21/2011 | WO2011045232A2 Neuropeptide-2 receptor (y-2r) agonists |
| 04/21/2011 | WO2011045202A1 Selective antagonist or agonist of amhrii for modulating fertility |
| 04/21/2011 | WO2011045081A1 Use of lactoferrin and lactoferrin-containing compositions |
| 04/21/2011 | WO2011044721A1 Use of spink6 gene and protein encoded therein in the manufacture of anti-tumor medicaments |
| 04/21/2011 | WO2011044701A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
| 04/21/2011 | WO2011044636A1 Na-k pump modulation |
| 04/21/2011 | WO2011026132A3 Methods and compositions for the inhibition of transplant rejection |
| 04/21/2011 | WO2011024110A3 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| 04/21/2011 | WO2011017297A3 Liposomes comprising a calcium phosphate - containing precipitate |
| 04/21/2011 | WO2011005593A3 Schistosomiasis vaccine compositions and methods of use |
| 04/21/2011 | WO2010147971A3 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 04/21/2011 | WO2010144742A3 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 04/21/2011 | WO2010144721A3 Model systems and treatment regimes for treatment of neurological disease |
| 04/21/2011 | WO2010144231A3 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/21/2011 | WO2010141866A3 Soga polynucleotides and polypeptides and uses thereof |
| 04/21/2011 | WO2010141842A3 Interlaced method for treating cancer or a precancerous condition |
| 04/21/2011 | WO2010141810A3 Compositions and methods modulating mg29 for the treatment of diabetes |
| 04/21/2011 | WO2010141093A3 Co-signaling methods for treating cancers |
| 04/21/2011 | WO2010138794A3 Regulation of sodium channels by plunc proteins |
| 04/21/2011 | WO2010138637A3 Fibromodulin peptide |
| 04/21/2011 | WO2010138180A3 Compositions and methods for cardiac tissue repair |
| 04/21/2011 | WO2010135684A9 Bone morphogenetic proteins for the treatment of insulin resistance |
| 04/21/2011 | WO2010135662A3 Marker differentially expressed in cancer stem cells and methods of using same |
| 04/21/2011 | WO2010135655A3 Human skin substitutes expressing il-12 |
| 04/21/2011 | WO2010135527A3 Elastin for soft tissue augmentation |
| 04/21/2011 | WO2010129600A3 Fgf21 mutants and uses thereof |
| 04/21/2011 | WO2010129457A3 Vaccines against tularemia |
| 04/21/2011 | WO2010124085A3 Compositions and methods for preventing and treating uterine disease |
| 04/21/2011 | WO2010123945A3 Silk fibroin hydrogels and uses thereof |
| 04/21/2011 | WO2010117997A3 Peptide targeting of inner ear cells |
| 04/21/2011 | WO2010111525A9 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 04/21/2011 | WO2009155585A8 Dna-directed customization of analgesic compounds as a therapeutic modality |
| 04/21/2011 | WO2007011411A3 N-fragment of edema factor as an antigen for immunization against anthrax |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110092953 Flowable Carrier Matrix |
| 04/21/2011 | US20110092677 Modified transferin-antibody fusion proteins |
| 04/21/2011 | US20110092673 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092571 Compositions and methods for sirna inhibition of icam-1 |
| 04/21/2011 | US20110092450 Method of enhancing the mobilization of hematopoietic stem cells using tat-hoxb4h |
| 04/21/2011 | US20110092449 Treatment of fibrotic conditions |
| 04/21/2011 | US20110092448 Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092446 Compositions and methods for treatment of trauma |
| 04/21/2011 | US20110092445 Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses |
| 04/21/2011 | US20110092444 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
| 04/21/2011 | US20110092443 Cyclosporine compositions for enhancing nail growth |
| 04/21/2011 | US20110092442 Anticancer agent containing bl-angiostatin |
| 04/21/2011 | US20110092441 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 04/21/2011 | US20110092440 Method of regulating cell growth using a proteasome inhibitor |
| 04/21/2011 | US20110092439 Method of promoting wound healing |
| 04/21/2011 | US20110092438 Composition for external application comprising transcription factor decoy as active ingredient |
| 04/21/2011 | US20110092437 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/21/2011 | US20110092436 Compounds for treating symptoms associated with parkinson's disease |
| 04/21/2011 | US20110092435 Treatment of parkinson's disease |
| 04/21/2011 | US20110092434 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 04/21/2011 | US20110092433 Fgf9-related methods for treating anxiety |
| 04/21/2011 | US20110092432 Vascular aging inhibitor and anti-aging formulation |
| 04/21/2011 | US20110092431 Skin aging-inhibiting peptide |
| 04/21/2011 | US20110092430 Method and compound for the treatment of valvular disease |
| 04/21/2011 | US20110092429 Compositions and methods for producing gamma-carboxylated proteins |
| 04/21/2011 | US20110092428 Detecting and controlling abnormal hematopoiesis |
| 04/21/2011 | US20110092427 Polypeptide and pharmaceutical composition containing the polypeptide |
| 04/21/2011 | US20110092426 Oral calcitonin compositions and applications thereof |
| 04/21/2011 | US20110092425 Method of drug delivery for bone anabolic protein |
| 04/21/2011 | US20110092424 Production of glucagon like peptide 2 and analogs |
| 04/21/2011 | US20110092423 INHIBITORS OF Akt ACTIVITY |
| 04/21/2011 | US20110092422 Elastin based growth factor delivery platform for wound healing and regeneration |
| 04/21/2011 | US20110092421 Methods for generating new hair follicles, treating baldness, and hair removal |
| 04/21/2011 | US20110092420 Selenium containing modifying agents and conjugates |